Sacubitrilat
Jump to navigation
Jump to search
Clinical data | |
---|---|
Other names | LBQ657 |
ATC code |
|
Identifiers | |
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
UNII | |
ChEMBL | |
PDB ligand | |
Chemical and physical data | |
Formula | C22H25NO5 |
Molar mass | 383.444 g·mol−1 |
3D model (JSmol) | |
| |
|
Sacubitrilat (INN; or LBQ657) is the active metabolite of the antihypertensive drug sacubitril,[1] which is used in the treatment of heart failure.[2]
References
- ^ Solomon SD. "HFpEF in the Future: New Diagnostic Techniques and Treatments in the Pipeline". Boston. p. 48. Retrieved 2012-01-26.
- ^ "FDA approves new drug to treat heart failure". Food and Drug Administration. 7 July 2015.
Categories:
- Articles with short description
- Short description matches Wikidata
- Drugs not assigned an ATC code
- Chemical pages without DrugBank identifier
- Articles without KEGG source
- Drugs with no legal status
- Articles containing unverified chemical infoboxes
- Antihypertensive agents
- Biphenyls
- Carboxylic acids
- Amides
- All stub articles
- Cardiovascular system drug stubs